Cowealth Medical Holding Co Ltd

Cowealth Medical Holding Co., Ltd., together with its subsidiaries, engages in trading of medical equipment, reagents, and spare parts in Taiwan, China, and Hong Kong. The company operates in two segments, Sells Equipment, and Sells Reagents and Others. It is involved in the provision of supply chain management services for reagents and consumables to hospitals; procurement, distribution, and management of reagents and consumables for medical institutions; and send specialists to assist with tasks, including inventory control, demand forecasting, specialized departmental training, and application of information technology. The company also provides acme empowerment program, including al-assisted clinical decision support system, platform of management analysis and decision making, multi-channel coaxial-time-audio-video-image digital platform for operating rooms, and cross-strait medical resource platform. In addition, it provides equipment comprising CyberKnife Stereotactic Radiosurgery System, a non-invasive treatment alternative for cancerous and non-cancerous tumors, as well as other medical conditions requiring radiation therapy; LipiView Ocular Surface Interferometer and LipiView Thermal Pulsation System, a system designed to diagnose and address meibomian gland dysfunction; and MRIdian-Linac, an MRI-guided radiation therapy system. Further, the company engages in general investing; import and export medical equipment, reagents, and spare parts; nutrition, health, and social and economic consulting business; and provision of software development, IT equipment maintenance, and IT system maintenance, hospital management, business management, and economic information consulting services. Cowealth Medical Holding Co., Ltd. was founded in 1994 and is headquartered in Shanghai, China.